Disruption of perlecan binding and matrix assembly by post-translational or genetic disruption of dystroglycan function

被引:46
作者
Kanagawa, M
Michele, DE
Satz, JS
Barresi, R
Kusano, H
Sasaki, T
Timpl, R
Henry, MD
Campbell, KP
机构
[1] Univ Iowa, Dept Physiol & Biophys, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA
[2] Univ Iowa, Roy J & Lucille A Carver Coll Med, Howard Hughes Med Inst, Dept Neurol, Iowa City, IA 52242 USA
[3] Univ Iowa, Roy J & Lucille A Carver Coll Med, Howard Hughes Med Inst, Dept Internal Med, Iowa City, IA 52242 USA
[4] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Physiol & Biophys, Iowa City, IA 52242 USA
[5] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Pathol, Iowa City, IA 52242 USA
[6] Max Planck Inst Biochem, D-82152 Martinsried, Germany
来源
FEBS LETTERS | 2005年 / 579卷 / 21期
关键词
dystroglycan; laminin; perlecan; basement membrane; congenital muscular dystrophy; Large(myd) mouse;
D O I
10.1016/j.febslet.2005.07.059
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dystroglycan is a cell-surface matrix receptor that requires LARGE-dependent glycosylation for laminin binding. Although the interaction of dystroglycan with laminin has been well characterized, less is known about the role of dystroglycan glycosylation in the binding and assembly of perlecan. We report reduced perlecan-binding activity and mislocalization of perlecan in the LARGE-deficient Large(myd) mouse. Cell-surface ligand clustering assays show that laminin polymerization promotes perlecan assembly. Solid-phase binding assays provide evidence for the first time of a trimolecular complex formation of dystroglycan, laminin and perlecan. These data suggest functional disruption of the trimolecular complex in glycosylation-deficient muscular dystrophy. (c) 2005 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:4792 / 4796
页数:5
相关论文
共 21 条
[1]   The C-terminal domain V of perlecan promotes beta 1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycans [J].
Brown, JC ;
Sasaki, T ;
Gohring, W ;
Yamada, Y ;
Timpl, R .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 250 (01) :39-46
[2]   Dystroglycan: important player in skeletal muscle and beyond - Review [J].
Cohn, RD .
NEUROMUSCULAR DISORDERS, 2005, 15 (03) :207-217
[3]  
Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO
[4]  
2-R
[5]   Laminin polymerization induces a receptor-cytoskeleton network [J].
Colognato, H ;
Winkelmann, DA ;
Yurchenco, PD .
JOURNAL OF CELL BIOLOGY, 1999, 145 (03) :619-631
[6]   Characterization of recombinant perlecan domain I and its substitution by glycosaminoglycans and oligosaccharides [J].
Costell, M ;
Mann, K ;
Yamada, Y ;
Timpl, R .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 243 (1-2) :115-121
[7]   The N-terminal globular domain of the laminin α1 chain binds to α1β1 and α2β1 integrins and to the heparan sulfate-containing domains of perlecan [J].
Ettner, N ;
Göhring, W ;
Sasaki, T ;
Mann, K ;
Timpl, R .
FEBS LETTERS, 1998, 430 (03) :217-221
[8]   Mutant glycosyltransferase and altered glycosylation of α-dystroglycan in the myodystrophy mouse [J].
Grewal, PK ;
Holzfeind, PJ ;
Bittner, RE ;
Hewitt, JE .
NATURE GENETICS, 2001, 28 (02) :151-154
[9]   Expression and function of laminins in the embryonic and mature vasculature [J].
Hallmann, R ;
Horn, N ;
Selg, M ;
Wendler, O ;
Pausch, F ;
Sorokin, LM .
PHYSIOLOGICAL REVIEWS, 2005, 85 (03) :979-1000
[10]   A role for dystroglycan in basement membrane assembly [J].
Henry, MD ;
Campbell, KP .
CELL, 1998, 95 (06) :859-870